Tri Locum Partners LP Portfolio Holdings

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Tri Locum Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $374 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pfizer Inc with a value of $50.2M, Teva Pharmaceutical Industries LTD with a value of $49.7M, Natera, Inc. with a value of $40.3M, Stevanato Group S.P.A. with a value of $37.4M, and Argenx Se with a value of $33.9M.

Examining the 13F form we can see an decrease of $12.8M in the current position value, from $387M to 374M.

Tri Locum Partners LP is based out at New York, NY

Below you can find more details about Tri Locum Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $374 Million
Healthcare: $374 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$148B
$50.2 Million 13.4% of portfolio
1,732,935
Q3 2024 Added 190.31%
$23.2B
$49.7 Million 13.26% of portfolio
2,755,737
Q3 2024 Added 8.06%
$16.3B
$40.3 Million 10.78% of portfolio
317,439
Q3 2024 Added 37.67%
$6.27B
$37.4 Million 9.98% of portfolio
1,867,938
Q3 2024 Added 230.36%
$35.3B
$33.9 Million 9.05% of portfolio
62,474
Q3 2024 Reduced 16.21%
$5.49B
$32 Million 8.54% of portfolio
151,429
Q3 2024 Added 13.62%
$5.33B
$31 Million 8.29% of portfolio
271,922
Q3 2024 Added 139.91%
$17.3B
$19.7 Million 5.26% of portfolio
54,926
Q3 2024 Added 9.63%
$5.81B
$17.7 Million 4.72% of portfolio
362,270
Q3 2024 Added 1.61%
$2.54B
$17.1 Million 4.56% of portfolio
593,980
Q3 2024 New
$10B
$10.5 Million 2.81% of portfolio
143,920
Q3 2024 Reduced 54.53%
$2.06B
$9.6 Million 2.56% of portfolio
192,157
Q3 2024 Reduced 42.73%
$5.24B
$9.19 Million 2.45% of portfolio
43,287
Q3 2024 Reduced 33.76%
$4.01B
$8.24 Million 2.2% of portfolio
91,721
Q3 2024 Reduced 70.08%
$244B
$8.01 Million 2.14% of portfolio
67,257
Q3 2024 Added 5.4%
$13.2M
$33,000 0.01% of portfolio
30,606
Q1 2024 Reduced 15.34%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 335.27%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 New
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $374 Million
  • Prior Value $387 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 3 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email